These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8434383)

  • 1. Evidence that I-E-negative mice resistant to neonatal H-2 tolerance induction display ubiquitous thymic clonal deletion of donor-reactive T cells.
    Ruiz P; Streilein JW
    Transplantation; 1993 Feb; 55(2):321-8. PubMed ID: 8434383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential patterns of T cell clonal deletion in neonatal H-2 tolerance and I-E/Mls induced self-tolerance.
    Viciana AL; Nassiri M; Padmanabhan J; Streilein JW; Ruiz P
    Transpl Immunol; 1994 Sep; 2(3):208-17. PubMed ID: 8000849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific skin transplants activate allodestructive T cells in mice resistant to neonatal H-2 tolerance induction.
    Nassiri M; Viciana A; Streilein JW; Ruiz P
    Transplantation; 1993 Dec; 56(6):1460-7. PubMed ID: 8279020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of donor chimerism, alloreactive host T cells and memory cell development in thymi from mice resistant to neonatal transplantation tolerance.
    Ruiz P; Nassiri M; Viciana AL; Padmanabhan J; Streilein JW
    J Immunol; 1995 Jan; 154(2):633-43. PubMed ID: 7814872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
    Tomita Y; Khan A; Sykes M
    J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. IV. Significance of intrathymic chimerism of blood-born Ia+ cells in Mls tolerance.
    Hosono M; Kurozumi M; Inaba M; Ideyama S; Tomana M; Gyotoku J; Katsura Y; Hosokawa T
    Cell Immunol; 1991 Sep; 136(2):373-87. PubMed ID: 1831406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. I. Preferential induction of tolerance to Mls antigens and resistance to allo-MHC antigens.
    Hosono M; Kina T; Hosokawa T; Katsura Y
    Cell Immunol; 1986 Nov; 103(1):1-10. PubMed ID: 3542233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal tolerance induction in the thymus to MHC-class-II-associated antigens. V. Thymus medulla and the site for deletional signaling achievement in Mls tolerance.
    Hosono M; Kurozumi M; Ideyama S; Katsura Y
    Thymus; 1992 Aug; 20(1):31-45. PubMed ID: 1387744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrathymic deletion of CD8+ alloreactive T cells in a transgenic T cell receptor model of neonatal tolerance.
    Borenstein SH; Tao KS; West LJ; Chamberlain JW
    Transplantation; 2001 Dec; 72(11):1807-16. PubMed ID: 11740393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Powell TJ; Streilein JW
    Transpl Immunol; 1993; 1(2):114-25. PubMed ID: 8081769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class II tolerant T cells undergo apoptosis upon re-exposure to tolerogen in vivo.
    Alard P; Levy R; Kosiewicz M; Jones M; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):76-80. PubMed ID: 8762018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
    J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoid organ production of immunomodulatory eicosanoids in mice resistant to neonatal tolerance induction.
    Nassiri M; Viciana A; Padmanabhan J; Streilein JW; Ruiz P
    Transplantation; 1994 Jun; 57(11):1643-52. PubMed ID: 8009599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stage of negative selection in tolerance induction in neonatal mice.
    Ando T; Yoshikai Y; Matsuzaki G; Takimoto H; Nomoto K
    Immunology; 1991 Dec; 74(4):638-44. PubMed ID: 1838353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa.
    Speiser DE; Schneider R; Hengartner H; MacDonald HR; Zinkernagel RM
    J Exp Med; 1989 Aug; 170(2):595-600. PubMed ID: 2526850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of neonatal transplantation tolerance.
    Streilein JW; Mohler K; Wood PJ
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):82-7. PubMed ID: 2962357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
    Khan A; Tomita Y; Sykes M
    Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification.
    Wood PJ; Strome PG; Streilein JW
    J Immunol; 1987 Jun; 138(11):3661-8. PubMed ID: 2884256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.